The Advisory Committee on Immunization Practices (ACIP) is scheduled to meet from 11 a.m. to 4:30 p.m. ET. It is not expected that the panel will vote on the items on the agenda.
ACIP is a panel of external medical experts in the fields of vaccinology, immunology, pediatrics, internal medicine, nursing, virology, public health, infectious diseases and other sub-specialties. The CDC generally accepts its recommendations once the votes have been cast.
Tomorrow’s meeting was precipitated by this newly identified adverse event, Dr William Schaffner, professor in the Division of Infectious Diseases at Vanderbilt University Medical Center and member of ACIP, told CNN. “There will be no formal votes and will come to the conclusion that the risk of Covid is very high and the risks of the vaccine very low. Real, but very low,” he added.
The aim of ACIP tomorrow is to weigh in on the need for boosters and examine what data is currently available and published. “What [ACIP] will demonstrate tomorrow is that the evidence is very scarce, ”says Schaffner, which ultimately means that the group will not vote on boosters.
Earlier this month, Pfizer announced that it would seek approval to provide a third dose of its Covid-19 vaccine as a booster, citing data from Israel on the continued spread of the coronavirus and the limited effectiveness against the more transferable Delta variant.
Health officials including Dr.Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, continue to say the United States needs more data before recommending coronavirus vaccine boosters to anyone.
“The CDC and the FDA have said that based on the data we currently know, we don’t need a boost,” Fauci told CNN’s Chris Cuomo last week. “This is not to say that it will not change. In fact, we may need, at some point, to give reminders either at all levels or to certain selected groups, such as the elderly or those suffering from dementia. ‘underlying conditions. “